Cooper EL. 2004. Drug discovery, CAM and natural products. Evid Based Complement Alternat Med, 3: 215.
Coope EL. 2005. CAM, eCAM, bioprospecting: the 21st century pyramid. Evid Based Complement Alternat Med, 2: 125-127.
Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. 2001. The anti-malarial artesunate is also active against cancer. Int J Oncol, 18: 767-773.
Farjadian S, Asadi E, Doroudchi M, Dehaghani A, SamsamiTabei, SZ, Kumar, VP, Ghaderi A. 2003. High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res, 9: 121-125.
Forastiere A, Koch W, Trotti A, Sidransky D. 2001.Head and neck cancer. N Engl J Med, 345: 1890-1900.
Ghorbani A. 2005. Studies on pharmaceutical ethnobotany in the region of Turkmen Sahra, north of Iran :( Part 1): General results. J Ethnopharmacol, 102: 58-68.
Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science, 281: 1309–1312.
Hersey P, Zhang XD. 2001. How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer, 1: 142-150.
Hsiao WL, Liu L. 2010. The role of traditional Chinese herbal medicines in cancer therapy–from TCM theory to mechanistic insights. Planta Med, 76: 1118-1131.
Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65: 55-63.
Mousavi SH, Tavakkol Afsharic J. Brook A. 2008. Study of cytotoxic effects of saffron in MCF-7 Cells. IJPR, 4: 261-268.
Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I .2009. Direct toxicity of Rose Bengal in MCF-7 cell line: role of apoptosis. Food Chem Toxicol, 47: 855-859.
Parkin DM, Bray F, Ferlay J, Pisani P. 2005.Global cancer statistics, 2002. CA Cancer J Clin, 55: 74-108.
Sahranavard S, Naghibi F, Ghffari S. 2012. Cytotoxic activity of extracts and pure compounds of Bryonia aspera. Int J Pharm Pharmaceut Sci, 4: 541-543.
Sharifi AM, Mousavi SH, Bakhshayesh M, Khakinegad Tehrani F, Mahmoudian M, Oryan S. 2005. Study of correlation between lead-induced cytotoxicity and nitric oxide production in PC12 cells. Toxicol Lett, 160: 43–48.
Stewart BW, KleihuesP,editors. 2003. Cancer facts and figures. In World Health Organization; World cancer report. London. IACRPress.
Song SY, Lee I, Park C, Lee H, Hahm JC, Kang W K. 2005. Neolignans from Saururuschinens is inhibit PC-3 prostate cancer cell growth via apoptosis and senescence-like mechanisms. Int J Mol Med, 16: 517–523.
Tabrizi AD, Alizadeh M, Sayyah Melli M, Jafari M, Madarek E. 2006. Incidence rate of cervical cancer and precancerous lesions in East Azarbayjan, Iran. Asia Pac J Clin Oncol, 2: 87–90.
Taraphdar AK, Roy M, Bhattacharya RK. 2001. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Curr Sci, 80:1387–1396.
Tsao JCI, Zeltzer LK. 2005. Complementary and alternative medicine approaches for pediatric pain: a review of the state-of-the-science. Evid Based Complement Alternat Med, 2:149–159.
Zhang XD, Franco A, Myers K, Gray C, Nguyen T, Hersey P.1999. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res, 59: 2747–2753.